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Background: Dizziness or vertigo is associated with both vestibular-balance and psychological factors. A common
assessment tool is the Vertigo Symptom Scale (VSS) -short form, which has two subscales: vestibular-balance and
autonomic-anxiety. Despite frequent use, the factor structure of the VSS-short form has yet to be confirmed. Here,
we clarified the factor structure of the VSS-short form, and assessed the validity and reliability of the Japanese
version of this tool.
Methods: We conducted a cross-sectional, multicenter, psychometric evaluation of patients with non-central
dizziness or vertigo persisting for longer than 1 month. Participants completed the VSS-short form, the Dizziness
Handicap Inventory, and the Hospital Anxiety and Depression Scale. They also completed the VSS-short form a
second time 1–3 days later. The questionnaire was translated into Japanese and cross-culturally adapted. We
conducted a confirmatory factor analysis followed by an exploratory factor analysis. Convergent and discriminant
validity, internal consistency, and test-retest reliability were evaluated.
Results: The total sample and retest sample consisted of 159 and 79 participants, respectively. Model-fitting for a
two-subscale structure in a confirmatory factor analysis was poor. An exploratory factor analysis produced a
three-factor structure: long-duration vestibular-balance symptoms, short-duration vestibular-balance symptoms,
and autonomic-anxiety symptoms. Regarding convergent and discriminant validity, all hypotheses were clearly
supported. We obtained high Cronbach’s α coefficients for the total score and subscales, ranging from 0.758 to
0.866. Total score and subscale interclass correlation coefficients for test-retest reliability were acceptable, ranging
from 0.867 to 0.897.
Conclusions: The VSS-short form has a three-factor structure that was cross-culturally well-matched with previous
data from the VSS-long version. Thus, it was suggested that vestibular-balance symptoms can be analyzed separately
according to symptom duration, which may reflect pathophysiological factors. The VSS-short form can be used to
evaluate vestibular-balance symptoms and autonomic-anxiety symptoms, as well as the duration of vestibular-balance
symptoms. Further research using the VSS-short form should be required in other languages and populations.
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Vestibular-balance symptoms, such as vertigo and dizzi-
ness, affect approximately 20% of the population [1,2].
These often become chronic and can greatly impair daily
living [2,3]. Vestibular-balance symptoms are often ac-
companied and interact with psycho-physiological symp-
toms, especially anxiety, which may also have a great
impact on patient’s quality of life [4-6]. Therefore, the
clinical state of patients with vestibular-balance symptoms
cannot be completely evaluated with vestibular and bal-
ance function tests, such as caloric tests or posturography
[7,8]. Patient-reported scales assessing both vestibular-
balance and psycho-physiological factors are absolutely
necessary to evaluate severity of symptoms or effectiveness
of treatment, such as vestibular rehabilitation [9] and cog-
nitive behavioral therapy [10].
Two patient-reported scales have been widely used to
comprehensively evaluate patients with vestibular-balance
symptoms: the Dizziness Handicap Inventory (DHI) [7]
and the Vertigo Symptom Scale (VSS) [8]. The DHI evalu-
ates handicaps due to dizziness in daily life. The VSS,
which assesses patient-reported symptoms, has an advan-
tage over the DHI in that it is not just used to evaluate the
frequency of vestibular-balance symptoms, but also the
severity of autonomic-anxiety symptoms, which have a
great impact on quality of life. The VSS has the highest
comprehensive validity of the self-rated scales assessing
vertigo- or dizziness-related symptoms [11]. There are
two versions of the VSS: the long version (VSS-lv) and the
short form (VSS-sf). The VSS-lv includes 34 items that
were created on the basis of patient interviews. It can be
used to measure the symptom frequency over the past
year, which is useful for epidemiological research. Principal
component analysis of the VSS-lv reveals a three-factor
structure: acute attack of vertigo or vestibular-balance
symptom of long duration, vertigo of short duration
or vestibular-balance symptom of short duration, and
autonomic-anxiety symptom. From an empirical perspec-
tive, the first and second factors can be combined into one
subscale, such that the VSS-lv is defined as consisting of
two subscales: the Vestibular-balance subscale and the
Autonomic-anxiety subscale [8]. For consistency be-
tween research groups, the two-factor solution has
been employed continuously, although the optimal
number of factors was not examined or determined to
be ‘three factors’ [12-14].
The VSS-sf has 15 items derived from the VSS-lv.
However, the factor structure has not been thoroughly
confirmed. The VSS-sf was developed to measure symp-
tom frequency over 1 month, with the main goal of
assessing therapeutic effect, and has been used in clinical
trials [9,15]. Although the VSS-sf has been defined as
having two subscales, similar to the VSS-lv [16], a pre-
vious study failed to verify a simple two-factor structurefor the VSS-sf via factor analysis. In the study, the Kaiser
criterion and scree plot were employed to determine the
number of factors, and these yielded a two- and three-
factor solution, respectively. Ultimately, a two-factor
solution was adopted [17] for consistency with previ-
ous studies. However, recent guidelines recommend
the use of multiple methods that are better able to de-
termine the number of factors than the Kaiser criter-
ion [18,19]. Thus, our primary aim was to clarify the
factor structure of the VSS-sf using the recent recom-
mendations for factor analysis of Classical Test Theory
(CTT) [18,19]. We used factor analysis of CTT not
methods of Item Response Theory (IRT) because both
CTT and IRT are acceptable in COSMIN checklist,
which is the recent guideline for designing or report-
ing a study on measurement properties [20]. Our
secondary aim was to confirm the validity and reliabi-
lity of the VSS-sf Japanese version used in the present
study.Methods
Procedure and participants
We conducted a cross-sectional, multicenter, psycho-
metric evaluation. Participants were recruited from the
otolaryngology departments of four university hospitals
and two general hospitals (three in urban areas, two in
suburbs, and one in a rural area) in Japan from February
to September of 2013. Eligible participants included both
outpatients and inpatients with vertigo or dizziness persist-
ing for longer than 1 month. All participants were at least
20 years of age and were native Japanese speakers. Neuro-
otology experts excluded patients with vertigo or dizziness
caused by the central nervous system, and diagnosed all pa-
tients according to the Diagnostic Guideline of Equilibrium
Disorders by Japan Society for Equilibrium Research. The
Japan Society for Equilibrium Research has strong relation
with the Barany Society (the International Society for
Neuro-Otology), and the definitions of vestibular diseases
are nearly similar between these two societies [21].
All participants completed three self-administered
questionnaires, which included socio-demographic vari-
ables, on site. Participants who consented to the retest
study received an additional VSS-sf questionnaire, and were
instructed to complete it 1–3 days after the initial session.
They were asked to record the precise date of completion.
Outpatients and inpatients returned the retest question-
naire by mail and by hand, respectively. With respect to
test-retest reliability in the current study population, we
considered 1–3 days to be an appropriate interval for com-
pletion because 1) vertigo- or dizziness-related symptoms
can vary widely on the scale of several days, and 2) because
24- or 48-hour intervals have been adopted in previous
studies for similar populations [17,22].
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Vertigo Symptom Scale–short form (VSS-sf)
The Vertigo Symptom Scale-short form (VSS-sf ) is a 15-
item, self-report instrument that measures the frequency
of vertigo, dizziness, unsteadiness, and concomitant
autonomic/anxiety symptoms over the past month
(Table 1). The VSS-sf uses a five-point Likert scale: 0
(never), 1 (a few times), 2 (several times), 3 (quite
often [every week]), and 4 (very often [most days]).
The total score ranges from 0 to 60, and a higher score
indicates a higher frequency of symptoms. The VSS-sf
has two subscales: the Vestibular-balance subscale
(VSS-sf-V) and the Autonomic-anxiety subscale (VSS-
sf-A), although the VSS-sf comprises items extracted
from the VSS-lv, which has a three-factor structure
[8]. Both the internal consistency and test-retest reli-
ability of the original English version of the VSS have
been established [23,24]. The reliability and validity of
the Norwegian and Turkish versions have also been
verified [17,22].
Dizziness Handicap Inventory (DHI)
The Dizziness Handicap Inventory (DHI) is a 25-item,
self-report questionnaire that evaluates the impact of
dizziness or vertigo on quality of life, and can be used to
assess the severity and effect of therapeutic treatments.
Each item is rated on a three-point scale. A higher totalTable 1 Distribution profile of the vertigo symptom scale-sho
Item
Vertigo-balance subscale score (VSS-sf-V)
1 A feeling that either you, or things around you, are spinning or moving,
lasting less than 20 minutes
3 Nausea (feeling sick), vomiting
4 A feeling that either you, or things around you, are spinning or moving,
lasting more than 20 minutes
6 A feeling of being dizzy, disorientated or swimmy, lasting all day
8 Unable to stand or walk properly without support, veering or staggering
to one side
10 Feeling unsteady, about to lose balance, lasting more than 20 minutes
13 Feeling unsteady, about to lose balance, lasting less than 20 minutes
15 A feeling of being dizzy, disorientated or swimmy, lasting less than 20 m
Autonomic-anxiety subscale score (VSS-sf-A)
2 Hot or cold spells
5 Heart pounding or fluttering
7 Headache, or feeling of pressure in the head
9 Difficulty breathing, short of breath
11 Excessive sweating
12 Feeling faint, about to black out
14 Pains in the heart or chest region
Total score (VSS-sf-T)
SD: Standard Deviation; Skewness > 2.0 or kurtosis > 7.0 are in bold.score reflects a more severe handicap. The DHI com-
prises items on three subscales: Emotional (DHI-E: anx-
iety or mental stress influenced by dizziness or vertigo),
Functional (DHI-F: disability affecting daily living caused
by dizziness or vertigo), and Physical (DHI-P: dizziness or
vertigo provoked by specific self-motions). We employed
the original three-subscale structure from various factorial
solutions of the DHI [25]. The reliability and validity of
the original English and Japanese versions have been
established [7,26].
Hospital Anxiety and Depression Scale (HADS)
The Hospital Anxiety and Depression Scale (HADS) is a
14-item scale that evaluates general anxiety and depression
in patients in a non-psychiatric hospital setting. It com-
prises the Anxiety subscale (HADS-A) and the Depression
subscale (HADS-D), which both have seven items on a
four-point scale. Higher subscale scores indicate higher
levels of either anxiety or depression. The reliability and
validity of the HADS have been documented for both the
original and the Japanese version [27,28]. A score of eight
or above on the HADS-A and HADS-D reflects the pres-
ence of anxiety disorders and depression, respectively [29].
Translation and cross-cultural adaptation
The translation procedure involved four steps. First, two
native Japanese speakers independently translated thert form in the total sample (n = 159)
Mean ± SD Skewness Kurtosis Lowest (%) Highest (%)
10.1 ± 7.85 0.71 −0.32 8.2 0.6
1.53 ± 1.45 0.45 −1.21 34.0 13.8
0.96 ± 1.25 1.14 0.05 52.2 5.7
0.99 ± 1.36 1.20 0.07 54.1 10.1
1.53 ± 1.58 0.52 −1.32 39.0 20.8
1.13 ± 1.39 0.96 −0.45 48.4 10.7
0.89 ± 1.29 1.19 0.06 60.4 6.3
1.32 ± 1.37 0.69 −0.78 39.0 10.7
inutes 1.72 ± 1.47 0.33 −1.30 27.0 18.9
5.34 ± 4.96 1.11 0.95 17.0 0.0
1.20 ± 1.40 0.81 −0.70 47.2 10.7
0.82 ± 1.17 1.35 0.76 57.2 4.4
1.42 ± 1.34 0.62 −0.79 32.1 11.3
0.64 ± 1.10 1.80 2.34 66.0 4.4
0.58 ± 1.08 1.94 2.82 69.2 3.8
0.46 ± 0.90 2.09 3.76 73.6 1.3
0.21 ± 0.59 3.31 11.66 84.9 0.0
15.4 ± 11.3 0.86 0.30 3.1 0.0
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lators was a psychiatrist who was familiar with persistent
dizziness, while the other was a neuro-otologist who
specializes in somatic medicine. Second, the two transla-
tors met with a Japanese methodologist who specializes
in psychiatric clinical research to discuss the forward-
translated Japanese version. Third, the test was trans-
lated back into English by a neuro-otology specialist
who was blind to the original version. The back-
translator spoke both Japanese and English, and was
advised by a native English speaker who was also blind
to the original version. A set of guidelines regarding the
translation of health measurement instruments has
recommended that one translator have expertise on the
construct to be measured while the other has language
expertise but naivety regarding the topic [20]. However,
we chose the translators among a group of medical
doctors who were familiar with vestibular-balance symp-
toms, because the Japanese word “memai” encompasses
a wide range of concepts related to vestibular-balance
symptoms (e.g. vertigo, dizziness, unsteadiness, faintness,
and lightheadedness) and is thus difficult for non-
medical translators to translate forward or back cor-
rectly. Finally, the author of the original English version
confirmed semantic and conceptual equivalence between
the original and the back-translated English version. In a
meeting with five psychiatrists, a psychiatric nurse, and a
psychiatric methodologist, all translation steps were
approved and the provisional Japanese version was de-
clared to be idiomatic and conceptually equivalent to the
original English version of the test.
Next, for cross-cultural adaptation, the provisional
Japanese version was tested on six Japanese patients with
persistent dizziness pre- and post-cognitive behavioral
therapy. Three of the patients reported that the phrasing
of two anchor points (the Japanese translation of “quite
often” and “very often”) were difficult to distinguish
from one another. In fact, these phrases did not reflect
therapeutic changes in the three patients, even though
the frequency of their symptoms was clearly improved.
An additional meeting of the group of experts described
above concluded that the meanings of these original
English phrases were difficult to describe appropriately
using simple Japanese words. Consequently, we added
concrete numeric values for each anchor point, which
we obtained from the author of the original version: 0
(None), 1 (A few times [approximately 1–3 times]), 2
(Several times [approximately 4–6 times]), 3 (frequent
[more than approximately seven times in less than ap-
proximately 14 days]), and 4 (extremely frequent [during
a period of approximately 15 days]). Another group of
six Japanese patients with persistent dizziness and simi-
lar treatment conditions were able to understand these
fixed expression anchor points with no difficulty. Totalscores on the VSS-sf seemed to clearly reflect patient
therapeutic changes. Thus, we conclusively defined the
final Japanese version of the VSS-sf.
Data screening and floor/ceiling effects
Cases with outlying or missing values were excluded.
We checked whether each item in the VSS-sf was nor-
mally distributed. Guidelines suggested that we could as-
sume a normal distribution when skewness and kurtosis
were no greater than 2.0 and 7.0, respectively [18]. Floor
or ceiling effects are considered to be present when
more than 15% of participants achieve the lowest or
highest possible scores [30].
Dimensionality (structural validity)
First, we conducted a confirmatory factor analysis (CFA)
assuming a two-factor model, which corresponds to two
subscales: VSS-sf-V and VSS-sf-A. We used a maximum
likelihood method assuming that each VSS-sf item
followed a normal distribution. Otherwise, we used a
generalized least square method. We examined the fol-
lowing model fit criteria: standardized root mean square
residual (SRMR), comparative fit index (CFI), and root
mean square error of approximation (RMSEA). Guide-
lines suggested that an SRMR equal to 0.08 or below,
CFI equal to 0.95 or above, and RMSEA equal to 0.05 or
below are indicative of good fit [18].
If the results of the CFA suggested an insufficient
model fit, we conducted an exploratory factor analysis
(EFA). To evaluate the suitability of the data for EFA, we
calculated Bartlett’s test for sphericity and the Kaiser–
Meyer–Olkin measure of sampling adequacy (KMO),
which should exceed the recommended minimum value
of 0.60. To determine the optimal number of factors,
multiple criteria were examined. These included the Kai-
ser criterion (“eigenvalue greater than one” rule), scree
plot, parallel analysis, minimum average partial (MAP)
procedure, and Bayesian information criterion (BIC). We
calculated both the MAP and BIC values for a one-
factor to seven-factor solution, and calculated the num-
ber of factors in which each value was minimized.
Guidelines suggested that researchers should use mul-
tiple methods to determine the number of factors and
should emphasize methods known to perform better
(such as parallel analysis and the MAP procedure) more
than those known to provide biased estimates (such as
the Kaiser criterion) [18,19]. Because we assumed that
there would be interfactor correlations, we used oblique
rotations: the direct Oblimin rotation and the Promax
rotation.
Other psychometric properties
For construct validity (convergent/discriminant validity),
we examined the following three hypotheses with Pearson
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Regarding the strength of relationships, we followed sev-
eral suggestions that the relationship should be regarded
respectively as large, moderate, and weak if the correlation
coefficiant was around ±0.50, ±0.30, and ±0.10 [31,32].
 Hypothesis 1: The total score on the VSS-sf
(VSS-sf-T) should have a large positive correlation
(r > 0.50) with the DHI total score (DHI-T) because
the frequency of vertigo-balance symptoms and
coexisting autonomic-anxiety symptoms is expected
to relate to handicaps resulting from dizziness.
 Hypothesis 2: The VSS-sf-V score should have a
large positive correlation (r > 0.50) with the DHI-T,
and a moderate or weak positive correlation
(0.10 < r < 0.50) with the HADS-D. We assumed
that the frequency of vertigo and dizziness was
related to handicaps resulting from dizziness,
and to a smaller degree, depressive symptoms.
 Hypothesis 3: The VSS-sf-A score should have a
large positive correlation (r > 0.50) with the HADS-A,
and a moderate or weak positive correlation
(0.10 < r < 0.50) with the DHI-P. We supposed that
the frequency of autonomic-anxiety symptoms
associated with vertigo and dizziness was related to
general levels of anxiety, and to a smaller degree, the
severity of dizziness provoked by self-motion.
Internal consistency is considered to be good when
Cronbach’s α coefficient is between 0.70 and 0.95 [30].
We calculated Cronbach’s α coefficients for the VSS-sf-
T, VSS-sf-V, and VSS-sf-A.
Regarding the test-retest reliability (reproducibility) of
the VSS-sf-T, VSS-sf-V, and VSS-sf-A, we calculated in-
terclass correlation coefficients (ICC) as a measure of
absolute agreement for single measures under a two-way
random model. An ICC of 0.70 is recommended as a
minimum standard for reliability [30]. As a sensitivity
analysis to examine the effect of the retest interval, we
also calculated ICCs for two subgroups: a 1-day interval
subgroup and a 2- or 3-day interval subgroup.
Sample size, statistical analysis, and ethics
We set the sample size at 150 because the adequate
subject-to-variable ratio for factor analysis has been
known empirically to range from 4:1 to 10:1, with a mini-
mum of 100 subjects [20]. The target size of the retest
sample was greater than 50 [30].
We used three methods to determine the number of
factors in the EFA (parallel analysis, MAP procedure,
and BIC), which were conducted with R ver. 3.0.2 (The
R Foundation for Statistical Computing, Vienna, Austria)
and EZR ver. 1.24 (Saitama Medical Center, Jichi Medical
University, Saitama, Japan) [33], which is a graphical userinterface for R. CFA was performed with SPSS Amos for
Windows ver. 22.0 J. All other analyses were performed
with SPSS Statistics for Windows ver. 22.0 J. A two-tailed
P of less than 0.05 was considered to be significant.
The ethical committee of Nagoya City University
Graduate School of Medical Sciences and similar ethical
review boards at all other study sites approved the study,
which followed the guidelines set by the Helsinki Declar-
ation. Written informed consent was obtained from all
participants.Results
Data quality and floor/ceiling effects
A total of 191 patients completed the questionnaires.
Excluding cases with missing values, the total sample of
the study contained 159 participants (83.2%). We found
no influential outliers and no systematic differences
between the total sample and the excluded cases. The
retest sample contained 79 participants. Table 2 summa-
rizes the demographic characteristics and clinical status
of the total and retest samples. Table 1 shows how two
items of the VSS-sf were considered not to follow a
normal distribution and that neither the floor nor ceiling
effect were observed in the total and subscale scores,
except for the floor effect in the VSS-sf-A.Dimensionality (structural validity)
We used the generalized least square method for both the
CFA and EFA because the VSS-sf had two non-normally
distributed variables. All model-fit indices for the CFA
examining the assumed two-factor simple structure
showed a poor model fit: the SRMR, CFI, and RMSEA
were 0.1175, 0.407, and 0.093 (90% confidence inter-
val: 0.077–0.110), respectively.
Thus, we conducted an EFA. Bartlett’s test for spher-
icity was significant (p < 0.001) and the KMO was 0.80,
which confirmed that the data were suitable for EFA. Re-
garding the number of factors, the results of the Kaiser
criterion, scree test, parallel analysis, and BIC indicated
that a three-factor solution was the best fit. Although
the MAP value in a two-factor solution was the smallest,
the MAP values in solutions from one- to three-factors
were nearly equal to each other. Therefore, we compre-
hensively concluded that the optimal number of factors
was three. We assessed the factor pattern and factor
structure matrix with commonality and interfactor cor-
relations from EFA using a direct Oblimin rotation with
delta = 0 (Table 3). We confirmed that a Promax rotation
provided similar solutions. One of three factors corre-
sponded exactly to the VSS-sf-A subscale. The other two
factors appeared to comprise four “vestibular-balance
short-duration symptom” items and four “vestibular-bal-
ance long-duration symptom” items in the VSS-sf-V,
Table 2 Demographic characteristics and clinical status of the study sample
Total sample (n = 159) Retest sample (n = 79)
n (%) n (%)
Male 55 (34.6) 28 (35.4)
Age (year)* 57.4 ±16.8 57.5 ±16.4
Marital status
Married 106 (66.7) 51 (64.6)
Unmarried/Divorced/Widowed 53 (33.3) 28 (35.4)
Educational status
Junior high school/High school 93 (58.5) 46 (58.2)
Junior college/University 66 (41.5) 33 (41.8)
Occupational status
Full-time worker 51 (32.1) 28 (35.4)
Part-time worker 14 (8.8) 4 (5.1)
Housewife 42 (26.4) 20 (25.3)
Student 1 (0.6) 1 (1.3)
Others 51 (32.1) 26 (32.9)
Diagnosis
Ménière’s disease 41 (25.8) 20 (25.3)
Benign paroxysmal positional vertigo 16 (10.1) 9 (11.4)
Vertebrobasilar artery insufficiency 13 (8.2) 5 (6.3)
Vestibular neuronitis 12 (7.5) 9 (11.4)
Sudden deafness with vertigo or dizziness 5 (3.1) 3 (3.8)
Vestibular migraine 3 (1.9) 2 (2.5)
Acoustic nerve tumor 3 (1.9) 1 (1.3)
Other vestibular diseases† 14 (8.8) 10 (12.7)
Vertigo or dizziness without any other vestibular disease‡ 52 (32.7) 20 (25.3)
Disease duration (month)* 57.9 ±72.5 61.3 ±68.2
Inpatient 31 (19.5) 26 (32.9)
Mental status
Clinical anxiety (HADS-A≥ 8) 56 (35.2) 30 (38.0)
Clinical depression (HADS-D≥ 8) 64 (40.3) 32 (40.5)
*Mean ± SD. †Vestibular diseases which are not defined by the diagnostic guideline of Japan Society for Equilibrium Research, such as unexplained vestibular
dysfunction, age-related vestibular dysfunction. ‡Including psychogenic dizziness without any other vestibular disease. HADS-A/D: Hospital Anxiety and Depression
Scale-Anxiety/Depression subscale.
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matrix subjected to EFA is available upon request.
Other psychometric properties
The total and subscale scores of the three questionnaires
were considered to be normally distributed because of
their skewness < 2.0, kurtosis < 7.0, and distribution
graphs. Therefore, we employed the Pearson correlation
coefficient to assess the construct validity. The correl-
ation matrix for the convergent/discriminant validity
is shown in Table 4, supporting all three hypotheses
clearly. Regarding internal consistency, the Cronbach’s α
coefficient for the VSS-sf-T, VSS-sf-V, and VSS-sf-Awere considered to be good: 0.866, 0.853, and 0.758, re-
spectively. The ICC values for test-retest reliability are
shown in Table 5. The ICC values in the retest sample
and each subgroup were acceptable.
Discussion
The present study is, to the best of our knowledge, the
first to clarify the dimensionality of the VSS-sf in a
manner recommended by the recent guidelines for
factor analysis [18-20]. Our most important finding
was that the VSS-sf in our Japanese sample consisted
of three factors that were well-matched with the three
factors in the VSS-lv in British, Mexican, and German
Table 3 Factor pattern/structure matrix, commonality, and interfactor correlation in exploratory factor analysis
Pattern coefficient Structure coefficient
Outline of item F1 F2 F3 F1 F2 F3 h2
Vertigo-balance subscale
10 Unsteadiness (>20 minutes) 0.868 0.000 0.044 0.887 −0.416 0.413 0.838
4 Vertigo (>20 minutes) 0.742 −0.103 −0.069 0.760 −0.422 0.281 0.742
3 Nausea, vomiting 0.463 0.048 0.182 0.518 −0.227 0.362 0.469
6 Dizziness (all day) 0.427 −0.364 0.093 0.634 −0.592 0.397 0.673
15 Dizziness (<20 minutes) −0.160 −0.947 0.093 0.317 −0.905 0.344 0.865
1 Vertigo (<20 minutes) 0.081 −0.746 −0.092 0.386 −0.752 0.193 0.781
13 Unsteadiness (<20 minutes) 0.077 −0.672 0.111 0.435 −0.745 0.370 0.665
8 Difficulty in standing or walking 0.372 −0.427 0.016 0.576 −0.604 0.318 0.612
Autonomic-anxiety subscale
9 Shortness of breath −0.177 −0.062 0.838 0.207 −0.262 0.784 0.693
14 Chest pain −0.035 0.140 0.693 0.195 −0.078 0.631 0.520
5 Heart pounding 0.169 0.000 0.504 0.382 −0.247 0.575 0.521
12 Feeling faint 0.193 −0.035 0.500 0.421 −0.292 0.594 0.477
2 Chills or hot flushes 0.147 −0.041 0.472 0.366 −0.267 0.548 0.487
11 Excessive sweating −0.044 −0.127 0.461 0.210 −0.262 0.485 0.511
7 Headache 0.167 −0.099 0.351 0.361 −0.294 0.455 0.391




Exploratory factor analysis used the generalized least square method, direct Oblimin rotation with delta = 0. Factor pattern/structure coefficients of 0.300/0.450 or
more, respectively, are in bold. Factor 1 (F1): Vestibular-balance long-duration symptom; Factor 2 (F2): Vestibular-balance short-duration symptom; Factor 3 (F3):
Autonomic-anxiety symptom; h2: commonality.
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toms of patients with vertigo or dizziness may consist
of three factors with cross-cultural consistency: the
Vestibular-balance long-duration symptom, Vestibular-
balance short-duration symptom, and Autonomic-anxiety
symptom.Table 4 Construct validity: Pearson correlation coefficients be




DHI-T 0.557 0.521 0.440
DHI-E 0.487 0.434 0.418 0.906
DHI-F 0.508 0.474 0.402 0.935
DHI-P 0.485 0.482 0.339 0.799
HADS-A 0.558 0.425 0.595 0.555
HADS-D 0.484 0.390 0.480 0.534
All correlations are significant (p < 0.001). Values in bold indicate the relationships m
form Total score/Vestibular-balance subscale/Autonomic-anxiety subscale; DHI-T/E/F
subscale/Physical subscale; HADS-A/D: Hospital Anxiety and Depression Scale-AnxieThe first well-known self-administered questionnaire
for measuring vestibular-balance symptoms is the DHI,
which Jacobson developed in 1990 to evaluate the extent
of handicaps due to dizziness [7]. Around the same time,
in 1992, Yardley developed the VSS, which has an advan-
tage in that it can be used to evaluate the frequency oftween variables




0.590 0.467 0.337 0.746
entioned in the prior hypotheses. VSS-sf-T/V/A: Vertigo Symptom Scale-short
/P: Dizziness Handicap Inventory-Total score/Emotional subscale/Functional
ty subscale/Depression subscale.
Table 5 Intraclass correlation coefficients for test-retest reliability
1 to 3-day interval (n = 79) 1-day interval (n = 45) 2 or 3-day interval (n = 34)
VSS-sf-T 0.888 [0.829-0.927] 0.921 [0.861-0.956] 0.848 [0.717-0.921]
VSS-sf-V 0.867 [0.800-0.913] 0.899 [0.823-0.943] 0.833 [0.693-0.913]
VSS-sf-A 0.897 [0.839-0.934] 0.920 [0.853-0.956] 0.869 [0.756-0.932]
[ ]: 95% confidence interval. VSS-sf-T/V/A: Vertigo Symptom Scale-short form Total score/Vestibular-balance subscale/Autonomic-anxiety subscale.
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anxiety symptoms, which have a strong impact on quality
of life. At the time, Yardley made the important point that
the VSS-lv has a three-factor structure: the Vestibular-
balance long-duration symptom, Vestibular-balance short-
duration symptom, and Autonomic-anxiety symptom [8].
Nevertheless, the two-subscale structure has been defined
from the perspective of empirical observation, and has been
employed widely since then. In two following principle
component analysis studies, the VSS-lv was defined as con-
sisting of two factors even though a three-factor solution
was indicated by a scree plot, which was the only reliable
method for determining the appropriate number of factors
in these studies [12,13]. Moreover, a following study ana-
lyzed the VSS-lv using a two-factor solution without exam-
ining the number of factors [14]. It appears that the
empirically determined two-subscale structure has had a
huge effect on the following methodologies in studies re-
garding the dimensionality of the VSS-lv and the VSS-sf.
We suggest that both the VSS-lv and VSS-sf be analyzed
not as empirical two-factor solutions but as statistics-based
three-factor solutions, at least in clinical research.
We further suggest that vestibular-balance symptoms
be analyzed separately, according not only to the symp-
tom aspects (vertigo, dizziness, and unsteadiness) but
also the symptom durations (vestibular-balance symp-
tom lasting more [or less] than 20 minutes), which may
better reflect pathophysiological factors behind the
symptoms. For example, there are items in the VSS-lv
that assess vertigo, dizziness, and unsteadiness lasting
less than 2 minutes, and these items did not load on
the Vestibular-balance factor but did load on the
Autonomic-anxiety factor [12]. In the present study,
the factor on which the items of vertigo, dizziness,
and unsteadiness loaded depended on whether the
symptom duration was more or less than 20 minutes.
Therefore, vestibular-balance symptoms appear to
have potentially different pathophysiological features,
according to their durations. This potentiality is sig-
nificant, especially for persistent vestibular-balance
symptoms, because they are thought to be related to
multiple factors, such as the vestibular system, the
somatosensory nervous system, the autonomic ner-
vous system, and psychological factors. Again, we sug-
gest that further studies examine the association
between symptom duration and other clinical features.A patient-reported outcome scale that can measure
distinctively different durations of vestibular-balance
symptoms should be useful in this regard.
Another key finding of the present study is that the
two subscales (the VSS-sf-V and VSS-sf-A) were clearly
divided with no cross-loading to the other subscale, and
that the two factors in the VSS-sf-V (the Vestibular-
balance long symptom and the Vestibular-balance short
symptom) were not sharply divided. This finding sug-
gests that the two-subscale structure of the VSS-sf may
have clear clinical interpretability. Meanwhile, three-
factor structures may be useful for the clinical research
mentioned above, although two cross-loading items
(dizziness lasting all day, difficulty standing or walk-
ing) may complicate interpretation. We suggest that
further studies examine the dimensional structure in
different cultural samples and develop a new patient-
reported outcome scale if necessary.
In the present study, we demonstrated that the VSS-sf
Japanese version has good psychometric properties over-
all. We found a slight floor/ceiling effect. The construct val-
idity was considered to be good. The internal consistency
and reproducibility were excellent.
The present study has some strengths. First, our sam-
ple can be considered to be representative of the target
population of individuals who complete the VSS-sf, be-
cause the sample cases were recruited based on diagno-
sis by neuro-otology specialists at multiple sites in
various locations. The demographic characteristics and
clinical status of the study sample (Table 2) are con-
sidered to be similar to those encountered in routine
clinical practice at otolaryngology clinics. Second, we
performed the cross-cultural adaptation process with
sufficient attention to both the semantic and concep-
tual aspects of the test. Contrary to the recommended
guidelines, we chose translators who were neuro-
otologists or psychiatrists because the translation of
Japanese phrases related to vestibular symptoms re-
quires a degree of familiarity with Japanese patient ex-
pressions of vestibular-balance symptoms. To account
for the absence of non-medical translators, we modi-
fied the Japanese text of the VSS-sf with an emphasis on
cognitive interviews with patients and clinical detectivity
of therapeutic change. Third, we used the recent recom-
mended methodology for factor analysis, specifically, the
method in which the optimal number of factors is
Kondo et al. Health and Quality of Life Outcomes  (2015) 13:4 Page 9 of 10determined, thus enhancing the clinical implications of
our study.
Several limitations should be taken into account when
interpreting the results of the present study. The first
limitation concerns the interval between the initial test
and the retest. The risk of recall bias cannot be denied
because of the short interval. However, our sensitivity
analysis of reproducibility showed that this risk was
minimal. There are no definite guidelines regarding the
optimal interval, which depends on both the target
population and the measured concept. We considered
the 1 to 3-day interval to be appropriate for the current
study population, as in previous studies. Second, we only
employed one back-translator although the guideline
recommends two independent back-translators [20]. To
compensate for this, we employed a native English
speaker who advised us regarding the back-translation,
ensured sufficient discussion between experts, and con-
ducted cognitive interviews with patients. Third, the
present study was conducted for the population in a sec-
ondary care context in Japan, using the Japanese version
of the VSS-sf. Further research is required in other lan-
guages and populations. Finally, we evaluated neither the
responsiveness nor interpretability of the VSS-sf in the
present study. Further research is required to examine
these properties.
Conclusions
In the present study, we demonstrated that the VSS-sf has
a three-factor structure, which includes Vestibular-balance
long-duration symptoms, Vestibular-balance short-duration
symptoms, and Autonomic-anxiety symptoms. These fac-
tors were cross-culturally well-matched with previous
studies using the VSS-lv. It was suggested that vestibular-
balance symptoms can be analyzed separately according to
symptom duration, which might reflect pathophysiological
factors. The VSS-sf is useful because it can be used to
easily evaluate not only vestibular-balance symptoms
and autonomic-anxiety symptoms, but also different
durations of vestibular-balance symptoms. Further re-
search using the VSS-sf should be required in other
languages and populations.
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